Study of Vanadium Supplement in Patients With Impaired Glucose Tolerance

Unidad de Investigacion Medica en Epidemiologia Clinica14 enrolled

Overview

The purpose of this study was to evaluate if the vanadium can improve the insulin sensitivity in patients with impaired glucose tolerance. Secondary purpose of this study was to assess changes on metabolic profile, weight and blood pressure.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Prediabetic State

Interventions

Vanadyl sulfateDIETARY_SUPPLEMENT

50 mg twice daily orally for a period of 4 weeks

Magnesium oxideOTHER

Validation of similar appearance and weight to the intervention component orally 1 unit (\<50 mg) twice daily for a period of 4 weeks

Eligibility

Sex: ALLMin age: 40 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosis of impaired glucose tolerance * Body mass index from 25 to 35 kg/m2 * History of type 2 diabetes mellitus in the first branch Exclusion Criteria: * Taking medication with known effects on carbohydrate or insulin metabolism * Thyroid diseases * Hepatic diseases

Locations (1)

Unidad de Investigacion Medica en Epidemiologia Clinica, Hospital de Especialidades, UMAE, Centro Medico Nacional de Occidente

Guadalajara, Jalisco, Mexico

Outcomes

Primary Outcomes

Changes on insulin sensitivity assessed with a euglycemic-hyperinsulinemic clamp technique

Time frame: 4 weeks

Secondary Outcomes

Changes on metabolic profile

Time frame: 4 weeks

Changes on anthropometrical measures

Time frame: 4 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.